Stock listing

OTC:REPCF RepliCel Life Sciences Inc. Stock

Follow RepliCel Life Sciences Inc. into a list and get an email when it puts out news.

Share price · OTC:REPCF

$0.0001 USD 0.0000 (0.0%)

Close on Oct 13, 2026 · Data provided by Twelve Data

RepliCel Life Sciences Inc. logo
Ticker
OTC:REPCF
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

Latest news

BCSC Revocation of Cease Trade Order

Aug 5, 2020

BCSC Cease Trade Order

Jun 17, 2020

RepliCel Announces its Incoming Board of Directors

Dec 23, 2019

RepliCel Provides 2019 Year-End Update

Nov 26, 2019

Clinical Data Published from RepliCel's Skin Rejuvenation Study

Sep 24, 2019

RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China

Sep 10, 2019

RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Automated Dermal Injector

Aug 29, 2019

RepliCel Secures Several New Patents for its Regenerative Medicine Technologies

Apr 16, 2019

RepliCel's Licensee Building Momentum in China with Facility and Team

Mar 26, 2019

RepliCel Reignites its First-in-Japan Strategy

Mar 19, 2019

All RepliCel Life Sciences Inc. news

Decks

RepliCel Life Sciences Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
85 in all · newest Aug 5, 2020 · oldest 2015
Decks
1 deck · latest May 2019

Log in to ask 6ix AI your own questions about RepliCel Life Sciences Inc.